Search Results - "Schechter, R"

A multicenter, open-label, randomized, phase II study of cediranib with or without lenalidomide in iodine 131-refractory differentiated thyroid cancer by Rosenberg, A.J., Liao, C.-Y., Karrison, T., de Souza, J.A., Worden, F.P., Libao, B., Krzyzanowska, M.K., Hayes, D.N., Winquist, E., Saloura, V., Prescott, K., Villaflor, V.M., Seiwert, T.Y., Schechter, R.B., Stadler, W.M., Cohen, E.E.W., Vokes, E.E.

“…Multitargeted tyrosine kinase inhibitors (TKIs) of the vascular endothelial growth factor receptor (VEGFR) pathway have activity in differentiated thyroid…”
Get full text

Postmastectomy Radiation Improves Local-Regional Control and Survival for Selected Patients With Locally Advanced Breast Cancer Treated With Neoadjuvant Chemotherapy and Mastectomy by HUANG, Eugene H, TUCKER, Susan L, SAHIN, Aysegul A, HORTOBAGYI, Gabriel N, BUCHHOLZ, Thomas A, STROM, Eric A, MCNEESE, Marsha D, KUERER, Henry M, BUZDAR, Aman U, VALERO, Vicente, PERKINS, George H, SCHECHTER, Naomi R, HUNT, Kelly K

“…To evaluate the efficacy of radiation in patients treated with neoadjuvant chemotherapy and mastectomy. We retrospectively analyzed the outcomes of 542…”
Get full text

Breast Conservation After Neoadjuvant Chemotherapy: The M.D. Anderson Cancer Center Experience by CHEN, Allen M, MERIC-BERNSTAM, Funda, SINGLETARY, S. Eva, AMES, Fredrick C, FEIG, Barry W, SAHIN, Aysegul A, PERKINS, George H, SCHECHTER, Naomi R, HORTOBAGYI, Gabriel N, BUCHHOLZ, Thomas A, HUNT, Kelly K, THAMES, Howard D, OSWALD, Mary Jane, OUTLAW, Elesyia D, STROM, Eric A, MCNEESE, Marsha D, KUERER, Henry M, ROSS, Merrick I

“…To determine patterns of local-regional recurrence (LRR) and ipsilateral breast tumor recurrence (IBTR) among patients treated with breast conservation therapy…”
Get full text

Is palpable DCIS more aggressive than screen-detected DCIS? by Balac, Nina, Tungate, Robert M., Jeong, Young Ju, MacDonald, Heather, Tung, Lily, Schechter, Naomi R., Larsen, Linda, Sener, Stephen F., Lang, Julie E., Brownson, Kirstyn E.

“…Palpable ductal carcinoma in-situ (pDCIS) is a subset of DCIS presenting with a clinical mass. We hypothesized pDCIS would have more aggressive clinical and…”
Get full text

Treatment of mucosa-associated lymphoid tissue lymphoma of the stomach with radiation alone by Schechter, N R, Portlock, C S, Yahalom, J

“…Mucosa-associated lymphoid tissue (MALT) lymphoma of the stomach (MLS) has recently been defined as a distinct clinicopathologic entity, often associated with…”
Get more information

Low-grade MALT lymphoma of the stomach: a review of treatment options by Schechter, N R, Yahalom, J

“…Low-grade mucosa-associated lymphoid tissue (MALT) lymphoma of the stomach (MLS) is often associated with the presence of Helicobacter pylori (H. pylori)…”
Get more information

Changes in the 2003 American Joint Committee on Cancer Staging for Breast Cancer Dramatically Affect Stage-Specific Survival by WOODWARD, Wendy A, STROM, Eric A, BUCHHOLZ, Thomas A, TUCKER, Susan L, MCNEESE, Marsha D, PERKINS, George H, SCHECHTER, Naomi R, SINGLETARY, S. Eva, THERIAULT, Richard L, HORTOBAGYI, Gabriel N, HUNT, Kelly K

“…To evaluate how implementation of the 2003 American Joint Committee on Cancer (AJCC) staging system will affect stage-specific survival of breast cancer…”
Get full text

Results of radiotherapy for T2N0 glottic carcinoma: does the "2" stand for twice-daily treatment? by Garden, Adam S, Forster, Ken, Wong, Pei-Fong, Morrison, William H, Schechter, Naomi R, Ang, K Kian

“…Radiotherapy (RT) is often the therapy of choice for patients with Stage T2 glottic carcinoma. This retrospective study updated the results of RT for patients…”
Get more information

Potential mechanisms for hypoalgesia induced by anti-nerve growth factor immunoglobulin are identified using autoimmune nerve growth factor deprivation by Hoffman, E.M, Zhang, Z, Anderson, M.B, Schechter, R, Miller, K.E

“…Abstract Nerve growth factor (NGF) antagonism has long been proposed as a chronic pain treatment. In 2010, the FDA suspended clinical trials using tanezumab, a…”
Get full text

Adjuvant irradiation for cervical lymph node metastases from melanoma by Ballo, Matthew T., Bonnen, Mark D., Garden, Adam S., Myers, Jeffrey N., Gershenwald, Jeffrey E., Zagars, Gunar K., Schechter, Naomi R., Morrison, William H., Ross, Merrick I., Kian Ang, K.

“…BACKGROUND The risk of regional disease recurrence after surgery alone for lymph node metastases from melanoma is well documented. The role of adjuvant…”
Get full text

The ζ-Potential of Gas Bubbles by Graciaa, A., Morel, G., Saulner, P., Lachaise, J., Schechter, R.S.

“…A technique for measuring the ζ-potential of a gas-liquid interface that overcomes the valid criticisms of previous attempts is proposed and demonstrated for…”
Get full text

Notes From the Field: Pertussis—California, January–June 2010 by Winter, K, Harriman, K, Schechter, R, Yamada, E, Talarico, J, Chavez, G

“…The number of pertussis cases reported to the California Department of Public Health has increased substantially during 2010. The increase in cases was first…”
Get full text

Wound Botulism in California, 1951–1998: Recent Epidemic in Heroin Injectors by Werner, S. Benson, Passaro, Douglas, McGee, James, Schechter, Robert, Vugia, Duc J.

“…California has reported most of the world's wound botulism (WB) cases and nearly three-fourths of the cases reported in the United States. We reviewed the…”
Get full text

Predictors of locoregional recurrence in patients with locally advanced breast cancer treated with neoadjuvant chemotherapy, mastectomy, and radiotherapy by Huang, Eugene H, Tucker, Susan L, Strom, Eric A, McNeese, Marsha D, Kuerer, Henry M, Hortobagyi, Gabriel N, Buzdar, Aman U, Valero, Vicente, Perkins, George H, Schechter, Naomi R, Hunt, Kelly K, Sahin, Aysegul A, Buchholz, Thomas A

“…To identify the clinical and pathologic factors predictive of locoregional recurrence (LRR) after neoadjuvant chemotherapy, mastectomy, and radiotherapy. We…”
Get more information

Clinically Relevant Pneumonitis After Sequential Paclitaxel-Based Chemotherapy and Radiotherapy in Breast Cancer Patients by Yu, Tse-Kuan, Whitman, Gary J., Thames, Howard D., Buzdar, Aman U., Strom, Eric A., Perkins, George H., Schechter, Naomi R., McNeese, Marsha D., Kau, Shu-Wan, Thomas, Eva S., Hortobagyi, Gabriel N., Buchholz, Thomas A.

“…Background: Taxane-based chemotherapy has been associated with an increased risk of radiation pneumonitis in patients with breast cancer. To obtain additional…”
Get full text

Radiation Oncology Practice Accreditation: A Story of the Surveyor Experience by Schechter, Naomi R.

Get full text

Is concurrent chemoradiation the treatment of choice for all patients with Stage III or IV head and neck carcinoma? by Garden, Adam S., Asper, Joshua A., Morrison, William H., Schechter, Naomi R., Glisson, Bonnie S., Kies, Merrill S., Myers, Jeffrey N., Kian Ang, K.

“…BACKGROUND Many patients with small primary tumors of the oropharynx have AJCC Stage III/IV disease on the basis of lymphadenopathy. In the current…”
Get full text

ACR-ARS Practice Parameter for Communication: Radiation Oncology by Saeed, Hina, Wallner, Paul E, Bates, James E, Chundury, Anupama, Freedman, Laura M, Mitin, Timur, Walker, Gary V, Small, Jr, William, Schechter, Naomi R

“…This practice parameter was revised collaboratively by the American College of Radiology (ACR), and the American Radium Society (ARS). Timely, accurate, and…”
Get full text

ACR-ARS Practice Parameter for Radiation Oncology by Lo, Simon, Chao, Samuel, Harris, Eleanor, Knisely, Jonathan, Luh, Join Y, Mohindra, Pranshu, Quang, Tony S, Ye, Jason, Small, Jr, William, Schechter, Naomi R

“…This practice parameter was revised collaboratively by the American College of Radiology (ACR), and the American Radium Society. This practice parameter…”
Get full text

Can positron emission tomography improve the quality of care for head-and-neck cancer patients? by Schechter, N R, Gillenwater, A M, Byers, R M, Garden, A S, Morrison, W H, Nguyen, L N, Podoloff, D A, Ang, K K

“…Fluoro-2-deoxy-d-glucose-positron emission tomography (FDG-PET) is a functional imaging modality that measures the relative uptake of 18FDG with PET. The…”
Get more information